Buttons: Top Navigation Bar
dual diagnosis management drug rehab center michigan addiction treatment oakland alcohol rehab california
dual diagnosis treatment and addiction treatment oklahoma city alternative alcohol rehab
1-800-559-9503 - drug rehab in dallas
Home > GAD > Quick Facts
GENERALIZED ANXIETY DISORDER Generalized Anxiety DisorderDisorder

Generalized anxiety disorder (GAD) is much more intense than the normal anxiety people experience on a day to day basis. This anxiety is chronic and fills one's everyday life with worry and tension, even when there wasn't anything really to provoke it. An individual with this disorder constantly worries excessively about everything from income, to friends and family, or employment. GAD is perhaps better characterized by the anticipation of disaster that usually is present in every moment of the afflicted individual's day. A rudimentary event like getting through the day is enough to provoke anxiety. People experiencing this anxiety, though they know it is irrational, cannot usually shake their fears.

 
Quick Facts   People with GAD
Symptoms   Treatment  
Research        
 
Quick Facts
GAD affects about 4 million adult Americans.
About twice as many women as men are affected by the disorder.
The disorder comes on gradually and can begin across the life cycle, though the risk is highest between childhood and middle age.
GAD is diagnosed when someone spends at least 6 months worrying excessively about a number of everyday problems.
There is evidence that genes play a modest role in GAD.
GAD is commonly treated with medications.
GAD rarely occurs alone, however; it is usually accompanied by another anxiety disorder, depression, or substance abuse.
Depression
Bipolar Disorder
Anxiety Disorders
Panic Disorders
Obsessive Disorder
PTSD
Schizophrenia
Social Phobia
BPD
Specific Phobias
Gad
References

Live chat by Boldchat

Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety ...

Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta(R) (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).

Cymbalta Receives European Approval for the Treatment of Generalised Anxiety ...

Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta® for the treatment of Generalised Anxiety Disorder . This approval -- the fourth for duloxetine in Europe -- was issued on 28 July following an initial positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use on 26 June 2008.

HomeSpacer Dual Diagnosis Spacer  Alcohol Detoxification Spacer  Drug Rehab Program SpacerSpacer
©2005 Dual Diagnosis, All Rights reserved